[1] 刘娟,吉文汇,闫芳.鸡大肠杆菌和沙门氏菌混合感染的分离鉴定及药敏试验研究[J].畜禽业,2007,(1):14-16. [2] 高崧,刘秀梵,张如宽,等.我国部分地区禽源性大肠杆菌的分离与鉴定[J].畜牧兽医学报,1999,30(2):164-171. [3] 韩克光,王安如,古少鹏,等.复配头孢噻呋对大肠杆菌的药敏试验[J].中国农学通报,2007,23(2):39-41. [4] 张希庆.滔罗定---抗感染药材料[EB/OL]. http://218.56.97.185:8081/Article_Show.asp?ArticleID=7925.2008-09-04. [5] Jurewitsch B, Jeejeebhoy KN. Taurolidine lock: The key to prevention of recurrent catheter-related bloodstream infections [J].Clinical nutrition, 2005, 24(3): 462-465. [6] Oguz H, Oguz E, Karadede S. Effect of taurolidine on the normal eyelid and conjunctival flora [J]. urrent Eye Research, 2000, 21(5): 851-855. [7] Torres Viera-C, Thauvin Eliopoulos-C, Souli M, et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis[J]. Antimicrobial Agents and Chemotherapy, 2000, 44(6): 1720-1724. [8] Calabresi P, Goulette FA, Darnowski JW. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent [J]. Cancer research, 2001, 61(18): 6816-6821. [9] Jacobi CA, Menenakos C, Braumann C. Taurolidine-a new drug with anti-tumor and anti-angiogenic effects [J]. Anti-cancer drugs, 2005, 16(9): 917-921. [10] Stendel R, Stoltenburg Didinger G, Al Keikh CL, et al. The effect of taurolidine on brain tumor cells [J]. Anticancer Research: International Journal of Cancer Research and Treatment, 2002, 22(2A): 809-814. [11] Braumann C, Henke W, Jacobi CA, et al. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis [J]. International Journal of Cancer, 2004, 112(2): 225-230. [12] Braumann C, Ordemann J, Wildbrett P, et al. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats[J]. Clinical & Experimental Metastasis, 2000, 18(7): 547-552. [13] 孙鎏国,孙小伟,李卫生,等.氟苯尼考对蛋鸡大肠杆菌病的疗效试验[J].兽药与饲料添加剂,2007,12(5):6-7. [14] 赵恒寿,赵英虎,黄姜生.两种新型制剂对人工诱发鸡白痢的疗效观察[J].山西农业大学学报:自然科学版,2004,24(2):160-162.
|